Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Priority to CU20100228ApriorityCriticalpatent/CU20100228A7/en
Publication of CU20100228A7publicationCriticalpatent/CU20100228A7/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Compuestos y síntesis de ácido L-glutámico marcado con [F-18], L-glutamato marcado con [F-18], sus derivados de acuerdo con la fórmula , y sus usos.Compounds and synthesis of L-glutamic acid labeled with [F-18], L-glutamate labeled with [F-18], its derivatives according to the formula, and their uses.
CU20100228A2010-11-192010-11-19
NEW DERIVATIVES OF L-GLUTAMIC ACID AND L-GLUTAMINE MARKED WITH [F-18] (1), ITS USE AND PROCEDURE FOR PREPARATION
CU20100228A7
(en)
DERIVATIVES OF 6- (6-SUBSTITUTED-TRIAZLOPIRIDACINA-SULFANIL) 5-FLUORO-BENZOTIAZOLOLES AND 5-FLUORO-BENCIMIDAZOLS: PREPARATION, APPLICATION AS MEDICATIONS AND USE AS MET INHIBITORS